Coagulation aggravates blood-induced joint damage in dogs

Arthritis and Rheumatism

Volumn 64, Issue 10, 2012, Pages 3231-3239

  Van Meegeren, Monique E R ^a   Roosendaal, Goris ^a   Barten Van Rijbroek, Angelique D ^b   Schutgens, Roger E G ^a   Lafeber, Floris P J G ^b   Mastbergen, Simon C ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATED BLOOD; ARTICLE; BLOOD; BLOOD CLOTTING; CARTILAGE MATRIX; COAGULATING BLOOD; CONTROLLED STUDY; CONVALESCENCE; DISEASE MODEL; EXPLANT; FEMALE; HEMARTHROSIS; HEMOPHILIA; HUMAN; HUMAN TISSUE; INFLAMMATION; JOINT INJURY; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN METABOLISM; SERUM; SYNOVITIS;

AGED; ANIMALS; BLOOD COAGULATION; CARTILAGE, ARTICULAR; DOGS; FEMALE; HEMARTHROSIS; HUMANS; INFLAMMATION; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; MALE; MIDDLE AGED; PROTEOGLYCANS;

EID: 84869030226     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34552     Document Type: Article

References (33)

1. Myers SL, Brandt KD, O'Connor BL, Visco DM, Albrecht ME. Synovitis and osteoarthritic changes in canine articular cartilage after anterior cruciate ligament transection: effect of surgical hemostasis. Arthritis Rheum 1990; 33: 1406-15. (Pubitemid 20365572)
2. Lafeber FP, Miossec P, Valentino LA. Physiopathology of haemophilic arthropathy. Haemophilia 2008;14 Suppl 4:3-9. (Pubitemid 351728992)
3. Valentino LA. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy. J Thromb Haemost 2010; 8: 1895-902.
4. Roosendaal G, Vianen ME, Marx JJ, Van Den Berg HM, Lafeber FP, Bijlsma JW. Blood-induced joint damage: a human in vitro study. Arthritis Rheum 1999; 42: 1025-32. (Pubitemid 29215015)
5. Hooiveld M, Roosendaal G, Wenting M, Van Den Berg M, Bijlsma J, Lafeber F. Short-term exposure of cartilage to blood results in chondrocyte apoptosis. Am J Pathol 2003; 162: 943-51. (Pubitemid 36237501)
6. Hooiveld MJ, Roosendaal G, Van Den Berg HM, Bijlsma JW, Lafeber FP. Haemoglobin-derived iron-dependent hydroxyl radical formation in blood-induced joint damage: an in vitro study. Rheumatology (Oxford) 2003; 42: 784-90. (Pubitemid 37220912)
7. Rodriguez-Merchan EC. Pathogenesis, early diagnosis, and prophylaxis for chronic hemophilic synovitis. Clin Orthop Relat Res 1997:6-11. (Pubitemid 27450788)
8. Roosendaal G, Vianen ME, Wenting MJ, van Rinsum AC, Van Den Berg HM, Lafeber FP, et al. Iron deposits and catabolic properties of synovial tissue from patients with haemophilia. J Bone Joint Surg Br 1998; 80: 540-5.
9. Harrold AJ. The defect of blood coagulation in joints. J Clin Pathol 1961; 14: 305-8.
10. McCarty WJ, Luan A, Siddiqui M, Hansen BC, Masuda K, Sah RL. Biomechanical properties of mixtures of blood and synovial fluid. J Orthop Res 2011; 29: 240-6.
11. Furmaniak-Kazmierczak E, Cooke TD, Manuel R, Scudamore A, Hoogendorn H, Giles AR, et al. Studies of thrombin-induced proteoglycan release in the degradation of human and bovine cartilage. J Clin Invest 1994; 94: 472-80. (Pubitemid 24250972)
12. Busso N, Morard C, Salvi R, Peclat V, So A. Role of the tissue factor pathway in synovial inflammation. Arthritis Rheum 2003; 48:651-9. (Pubitemid 36302000)
13. Yang YH, Hall P, Milenkovski G, Sharma L, Hutchinson P, Melis E, et al. Reduction in arthritis severity and modulation of immune function in tissue factor cytoplasmic domain mutant mice. Am J Pathol 2004; 164: 109-17. (Pubitemid 38364596)
14. Jansen NW, Roosendaal G, Bijlsma JW, DeGroot J, Lafeber FP. Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: an in vitro study. Arthritis Rheum 2007; 56: 199-207. (Pubitemid 46106192)
15. Esmon CT. Interactions between the innate immune and blood coagulation systems. Trends Immunol 2004; 25: 536-42. (Pubitemid 39208352)
16. Cirino G, Vergnolle N. Proteinase-activated receptors (PARs): crossroads between innate immunity and coagulation. Curr Opin Pharmacol 2006; 6: 428-34.
17. Cook JL, Kuroki K, Visco D, Pelletier JP, Schulz L, Lafeber FP. The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the dog. Osteoarthritis Cartilage 2010;18 Suppl 3:S66-79.
18. Marijnissen AC, van Roermund PM, TeKoppele JM, Bijlsma JW, Lafeber FP. The canine 'groove' model, compared with the ACLT model of osteoarthritis. Osteoarthritis Cartilage 2002; 10: 145-55. (Pubitemid 34120988)
19. Hooiveld M, Roosendaal G, Vianen M, Van Den Berg M, Bijlsma J, Lafeber F. Blood-induced joint damage: longterm effects in vitro and in vivo. J Rheumatol 2003; 30: 339-44. (Pubitemid 36152601)
20. Roosendaal G, Lafeber FP. Pathogenesis of haemophilic arthropathy. Haemophilia 2006;12 Suppl 3:117-21.
21. Lafeber FP, Vander Kraan PM, Van Roy JL, Huber-Bruning O, Bijlsma JW. Articular cartilage explant culture; an appropriate in vitro system to compare osteoarthritic and normal human cartilage. Connect Tissue Res 1993; 29: 287-99.
22. Kim YJ, Sah RL, Doong JY, Grodzinsky AJ. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 1988; 174: 168-76. (Pubitemid 18261664)
23. Wluka AE, Stuckey S, Snaddon J, Cicuttini FM. The determinants of change in tibial cartilage volume in osteoarthritic knees. Arthritis Rheum 2002; 46: 2065-72.
24. McAvoy TJ. The biologic half-life of heparin. Clin Pharmacol Ther 1979; 25: 372-9. (Pubitemid 9164954)
25. McCarthy HE, Singer ER, Davies Morel MC. The effect of sodium heparin on equine articular cartilage. Vet J 2001; 162: 73-9. (Pubitemid 32622391)
26. Tyagi SC, Kumar S, Katwa L. Differential regulation of extracellular matrix metalloproteinase and tissue inhibitor by heparin and cholesterol in fibroblast cells. J Mol Cell Cardiol 1997; 29: 391-404. (Pubitemid 27129162)
27. Lafeber FP, van Roy H, Wilbrink B, Huber-Bruning O, Bijlsma JW. Human osteoarthritic cartilage is synthetically more active but in culture less vital than normal cartilage. J Rheumatol 1992;19: 123-9.
28. Bjork I, Lindahl U. Mechanism of the anticoagulant action of heparin. Mol Cell Biochem 1982; 48: 161-82. (Pubitemid 13224668)
29. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001;119:64S-94S. (Pubitemid 32154195)
30. Morris R, Winyard PG, Blake DR, Morris CJ. Thrombin in inflammation and healing: relevance to rheumatoid arthritis. Ann Rheum Dis 1994; 53: 72-9. (Pubitemid 24067415)
31. Varisco PA, Peclat V, van Ness K, Bischof-Delaloye A, So A, Busso N. Effect of thrombin inhibition on synovial inflammation in antigen induced arthritis. Ann Rheum Dis 2000; 59: 781-7.
32. Cederholm-Williams SA. Concentration of plasminogen and antiplasmin in plasma and serum. J Clin Pathol 1981; 34: 979-81. (Pubitemid 11062203)
33. Stroncek D, Slezak S, Khuu H, Basil C, Tisdale J, Leitman SF, et al. Proteomic signature of myeloproliferation and neutrophilia: analysis of serum and plasma from healthy subjects given granulocyte colony-stimulating factor. Exp Hematol 2005; 33: 1109-17. (Pubitemid 41416959)